N
Google TrendMAX CASTER (200+) — Moose Def. Max Caster At TNA Bound For Glory 2026
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:max caster200+prince harry family photo story200+kelley knockel500+torino vs udinese200+coventry vs newcastle5000+levante - sevilla2000+servicio de control de inmigración y aduanas1000+indigo girls500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "First RAS Inhibitor Exten" (30 stories)

Top Headline Story

First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know
Lead StoryPancreatic Cancer Action Networkgeneral
Aug 26

First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQQ3pGR2lUVEZuRWZ6ak81R3RtMFFndU9EVG80ei12Sm53cnVpREJtOGUtclhJUGhEWklDaE04dlJBazV0UTQwOXd0NHdSTTVpbUYyQWZQZHR4RUN5S1kyQ1RfUkVmOE5jQ1BFRW03U043MV95UUhycEFITm5NZFEwc3UyaC1Odm95WWprbWdVcWw4Rmh0ZEZNejlvWUxhdmllaGZickJ0WmxBeXNielRHR2x3RUQ4MHBRam5oaG1xRXMyY3NoMHVuYnRHS2prRDJfY1hIeVd6TFY4dw?oc=5" target="_blank">First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know</a>  <font color="#6f6f6f">Pancreatic Cancer Action Network</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+16m ago

max caster

Moose Def. Max Caster At TNA Bound For Glory 2026

Filter stories
200+16m ago

prince harry family photo story

Prince Harry Reveals the Photo He Took of Archie and Lilibet That ‘Fills My Heart’

Filter stories
500+26m ago

kelley knockel

1 dead, multiple injured after pair of motorcycle crashes involving deer in Iowa

Filter stories
200+26m ago

torino vs udinese

Torino vs Udinese: Italian Serie A stats & head-to-head

Filter stories

Search Results for "First RAS Inhibitor Exten"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer
Harvard Medical Schoolgeneral

Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQLXA1dlhEUFpkUkZCb2VMNGRuTmx6TVVQWjlOcFZKbm8wR0p0RVRid09hRzRfdWpSbkZQTFk1clF2eGFBMXdhQnVyU05Ccjc0eUJnNTNnVENwRC1peWdHNGlZUC1aSm9zc2VYV0h6cXdiZ0dIZWl3eE5uN3NxY0FrRWxha2VuUFZsNkpCMWRfZGx5NXAxWU56dS0zZzBXNGp0Y3R4MXotYlNuRVNq?oc=5" target="_blank">Experimental Drug Doubles Median Survival in Patients With Metastatic Pancreatic Cancer</a>  <font color="#6f6f6f">Harvard Medical School</font>

Read Full StoryMore like this
FDA Approves First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer
HCPLivegeneral

FDA Approves First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNSXcyU25pLXlqaHhCaU9XSkRYT25ic0hYSzVPLWd3WEJsckdZQ0FOdmF0TWtOVGZhRm5MSlNWQnZjN3ExZkpCODd1MVBmMmtqV3FkbjIwZkg5bTBURVIxTkRocUJWcmNmMDlRQmUzZDZwVFlxQ3Y3bUIxSHJmUmI0YXMweW1LYkgzWnV6TEx4enp0WTJBVXYxTEswTVVXT2Y4SmlPQ2xB?oc=5" target="_blank">FDA Approves First-in-Class RAS Inhibitor for Metastatic Pancreatic Cancer</a>  <font color="#6f6f6f">HCPLive</font>

Read Full StoryMore like this
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
Naturegeneral

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqYkFNYngzZmtHeC13NTZNTmUtWnN1bWRTcUQ5eWZSTGNadGpWX0NMV2wySWpJWmNlT0NvSGVxOGNaMEZYZzRyUGJJMGNvSHNOWm9KMVJXTmdmWE85X01F?oc=5" target="_blank">Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
New Hope for Pancreatic Cancer With Targeted KRAS Drug
Memorial Sloan Kettering Cancer Centergeneral

New Hope for Pancreatic Cancer With Targeted KRAS Drug

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOLTk3QXlNZzZ6bFBUVTduVlQ1MjlHMkowMzNsVXJybk82WWcxallGbGhOQ19tS2x1X1JjS2RBeDNBNTd6Yld1bnF4S3Foa0YwRDBBRzRseVZ1bGVfc1FCV0FXd2xzZEptak1xS0pHRjNlaVNVMFpwZ0U1VVJTUkwwN3BHb1RTWlJx?oc=5" target="_blank">New Hope for Pancreatic Cancer With Targeted KRAS Drug</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Read Full StoryMore like this
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
Cure Todaygeneral

6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPM0c5NjV4NGtqUllYZkgwaVV1RkpKRXdZX3hRNk9YN3Y3VklyY2g4MmZKZ0gxNkhpX0NsZWdVS1NWa3JPcXROdm5raXhNcGZITXlEZEJ0WDlfUGZFVE9RWXQzVGVNdUVTbWVyV2JBUE5IdVR0VkRqRGlZR1lCcEhrXzUzU1NBY3dJZlR1RjJrQ3lzTXdROXVGbURnWkpHUk5QaXc?oc=5" target="_blank">6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
Investigational targeted therapy doubles survival in metastatic pancreatic cancer
UCLA Healthgeneral

Investigational targeted therapy doubles survival in metastatic pancreatic cancer

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOQ1NKRWpFTGpENFg3R2lCSEF2QkpWYnZSVEE1U0h3d25PcnR2S1UzVjlZQ3hWSGNqMDNhNnJRWHZHaU1CMHRGQlNrbkhud0JTOHl0LXBVZ1c5R3NrSHZXNWtEN0xBN3BwdzNuYmplZ1gyMUJKc3RqUXBpc3k4eGN1aGg3WklOb2h5aVhvTjNnc21KZWtYTkhEM0pOckI4NlpITXc?oc=5" target="_blank">Investigational targeted therapy doubles survival in metastatic pancreatic cancer</a>  <font color="#6f6f6f">UCLA Health</font>

Read Full StoryMore like this
A New Pill Could Transform How Pancreatic Cancer Is Treated
National Geographicgeneral

A New Pill Could Transform How Pancreatic Cancer Is Treated

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQNlFKdmItN25sNHU3aXc1VlUxbHdZNHhZUXhVazdLNWZJMGVxUnRMVS1TQVJ1a01XczAwelJCY0IyTkRyLVoyd05XV3UzdWJ1clc5cDg4SGdKRnFtak41MHoxM09DcXIzTGtYMWVncDdwLWFQVDRqaVdmQ0ZOU0M3OEZ5Y2lxNEVwQUprZXpoT2RQMC05VWpMZElxSU4tMTdJQ0RqMXJXSQ?oc=5" target="_blank">A New Pill Could Transform How Pancreatic Cancer Is Treated</a>  <font color="#6f6f6f">National Geographic</font>

Read Full StoryMore like this
St. Charles provides early access to new pancreatic cancer drug
Bend Bulletingeneral

St. Charles provides early access to new pancreatic cancer drug

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQUkp0QlNBcm5BVy1zam92MXJmbmE4MUNXMWstWEdpa3J3NDRtR2NiSFdDM2FYSzZ2amhxT2JWaF9JLUdoakZTOXZULWUtUGFrclVnbWxORlpEOGh0UDRrN05BRjJJMWJkU3Z0ZTZCdno4bEZFRnlZQVR2QXZVWkVSXy01c29EZVpDd2F2SkVPbVJOUjF6X0NIQ2FFZmNZR2pj?oc=5" target="_blank">St. Charles provides early access to new pancreatic cancer drug</a>  <font color="#6f6f6f">Bend Bulletin</font>

Read Full StoryMore like this
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
The New York Timesgeneral

How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPVngwQWRuOWdSOHhoUEZ2eGhQYU0weW5xSmRCbzFldHRFTkxLcjNtd2VONXduZ0pFcmhnNzM3bVAzVENtSHVjb0tGVTBvQ1V2WWxCTFZiRm5hUklUcDdnc09IYzNtaXNyN0pDVU5EcmQxUVRlU0Vydm8xdDEyQmFuNzBCbXZRQUhQNVE?oc=5" target="_blank">How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough</a>  <font color="#6f6f6f">The New York Times</font>

Read Full StoryMore like this
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
Yahoo Financetech

Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQOUtONEJEdW5TNWlMMGNWck5YNG9fcVQ0S3BxZFlOSFM3bGtVYkxocjNNRGtXdWs4V0Q4SElibGk3ZU9KUUVvdGlubDlUYUZENWlKdFl0R0kzdW03ZDNCc2dHS3JXUW1VN0FPU2FncUw0S3JjYVl5dUI0Zmw0TVdhdng4dEs1ZF9mdHhqMzhHSlgzNzJlc3BJc09uZURndw?oc=5" target="_blank">Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer
Memorial Sloan Kettering Cancer Centertech

New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOTnVlVjB5WEdpUHFJaXFBM2R3TUtBX0ZBRWhrZmRJaDczdlpsSXdoYlRVeEZrZi1lSFNFTW9UMVBKYVpTWlpMb1gzV2FmdEwwVXhJaFN3cDBOT2FxYlR2Y09BMXg2NnZsR0RDQUJ4aU5OeWdqNkdkNVJIdElLRV9XSHVkQnRWVEtEQVhBQm5n?oc=5" target="_blank">New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer</a>  <font color="#6f6f6f">Memorial Sloan Kettering Cancer Center</font>

Read Full StoryMore like this
BlossomHill plots IPO to fund pivotal study of EGFR inhibitor
FirstWord Pharmaworld

BlossomHill plots IPO to fund pivotal study of EGFR inhibitor

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFBseVFndXQ4RkxOWWZYWmd6czRPRk55eUlFMjFjRmZtQjN1c1R4bUlmNDVKdEZ3eVNnRVBNM21Dbk1pVThXanFDcDhKNlBTeEpLdDZJ?oc=5" target="_blank">BlossomHill plots IPO to fund pivotal study of EGFR inhibitor</a>  <font color="#6f6f6f">FirstWord Pharma</font>

Read Full StoryMore like this
Verastem CSO Pachter: The First RAS Drug Is a Floor, Not a Ceiling
BigGo Financegeneral

Verastem CSO Pachter: The First RAS Drug Is a Floor, Not a Ceiling

<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTFBscEtteXo3NEI1dUVSdC1aSWpCSk5FSXgwZUh4VjQ3ZkhEX2Q2OW9QbXVtNGh4UENfaXNWX1d0dU4tQkhBb1JlNk5aRGdIRHVGdV84X040Y3JsSDg?oc=5" target="_blank">Verastem CSO Pachter: The First RAS Drug Is a Floor, Not a Ceiling</a>  <font color="#6f6f6f">BigGo Finance</font>

Read Full StoryMore like this
Daraxonrasib Improves Survival in Metastatic Pancreatic Cancer
Cure Todaygeneral

Daraxonrasib Improves Survival in Metastatic Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPc0JIelV6eFF5bHRQVDE4bF90blJTWFBlRnJzTGhieGlLQ19qNVNyWS1qaEpYLWw5Qnp1cDV6NVM3QVlYdlJqd2xSYThVdEszcGlKZl9VVlJIU0RtVGZHVG9TRkl1YTdabUVWQnNxNXJETlp2TzNreld3RzRfY2lfYXBmdzBuVHRKVHN3cHN4RjNQb2RTNHAzYQ?oc=5" target="_blank">Daraxonrasib Improves Survival in Metastatic Pancreatic Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader
PR Newswireworld

PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader

<a href="https://news.google.com/rss/articles/CBMivAJBVV95cUxOMWtKQjN4UGRZc0Y4aUJkTEd2SlJXVjJXQWU1c2tvcDNmMGROUzhTR2dFYjlUdnRjTWNHRVNmOUNpdjNfb1kxLWd5Y04xald3RHkxRndNTkhYRV91QjZDUkxEOXNOQWJ2amtDZ2ZFZEhDZzhtUFpzaFI3RXpJR0M1LTIwZ3JGcmJ1TEJ2VGRHUDlrRGhOSTdnUmlnTjlMb0RRbHNaMzh3cXpoSjlyVGstWVBIVVZPbE9Mczk5akd3VkNmYW9yZE5hSmNFZnd0cXBsTkhQYm44QmoyVHlWMFZiQ3VkM3dIY01yOERKTVJ2TUtLZXo3bFVOMGxFUUJUSnpEa051UXI1OC1UNHdOeHJXMHN5M25jTVFtTzRrXzZ1WmtjSnpVM09kVFIzdURNY3hSblJnTUNNZ1dXWmo5?oc=5" target="_blank">PAQ Therapeutics Announces Series B Extension, Bringing Total Series B Financing to $77 Million; First Patient Dosed in Phase 1 Trial of PT0511, a Pan-KRAS Degrader</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Despite uncertainties, Travere’s Filspari emerges as first FDA-approved FSGS treatment
Fierce Pharmatech

Despite uncertainties, Travere’s Filspari emerges as first FDA-approved FSGS treatment

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPb0c1blJyMmpXanh0ajZvT0VTemJCMHBoQ3VjNGdmam5US3NuNjJiSHd6S0hpcHp5NUN6T0lpOWhkWTZRcmJyV29FNFNqSzVZZG5zTUlzaTEtbF9VQVJsei04YVpMdTFENFZua3Vabng4YVJfcnoxRE5UT19PV3JEMlZpeXB6cmYwNHNjTEt0akNST1BRcHd1SFFfR1lrdUM4cmJlRWtNS0loQQ?oc=5" target="_blank">Despite uncertainties, Travere’s Filspari emerges as first FDA-approved FSGS treatment</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations
Naturetech

The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5hTGdURld6ZDRPS09uMzRNc195ZTRELXJJTkstTmd6UjRRdFBaazhZNHBOTmhFUWtXSUhJNXJoUUo4R1NDX1JKY3hhbmJxUXRod3hHaGZ5aEJzVFJXb2pV?oc=5" target="_blank">The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
FDA approves targeted therapy for metastatic pancreatic cancer following UCLA-led study
UCLA Healthgeneral

FDA approves targeted therapy for metastatic pancreatic cancer following UCLA-led study

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQd1JMRmZmYU5wRFdDcENVZ3ZKV0FmY0JzdjExM0ZJY21RcnRMb3dONHEwQjZHN1NCeWVsSDJKU210WGVfNGhpc3MtOVAwNUNQRzd4eUlxSi1pRnVZcFFPcFVscF9BY0JJTzE5QVA2TmdIYjdFVjZPX2M0cVhfeHNCeFZsdkZhVlZNcGZybXoxeDBJMFhmNENXdG9QaFZCSTA?oc=5" target="_blank">FDA approves targeted therapy for metastatic pancreatic cancer following UCLA-led study</a>  <font color="#6f6f6f">UCLA Health</font>

Read Full StoryMore like this
Daraxonrasib extends survival in metastatic pancreatic cancer
2 Minute Medicinegeneral

Daraxonrasib extends survival in metastatic pancreatic cancer

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOMlJUNUEtX2NCbkRMRU5JLUJoal9rZDVIWFBwVFZpaDZFNDFXNnYySzVQUGV3QW1zWnlNZjV3eG5VdzNtMmRtRDd3QnJRWm1oQVl2azQxci02ZEF3TkdxeUFhaXp1YkdZeVUzZzZqc09wUlVvTWV3OWxaMkRaME5kdEJDYVVUdlNIdU5mZ09aUXZZZEJZZEdZcFJR?oc=5" target="_blank">Daraxonrasib extends survival in metastatic pancreatic cancer</a>  <font color="#6f6f6f">2 Minute Medicine</font>

Read Full StoryMore like this
The Survival Signal That Should Redesign Every RAS-Mutant Pancreatic Trial Running Right Now
The Clinical Trial Vanguardworld

The Survival Signal That Should Redesign Every RAS-Mutant Pancreatic Trial Running Right Now

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxQYldobVdWOHNrYlZpYTJoMkkzV05vTWZJNTJaeXp4am5hYXdhUzVJU1FuVlNRYzBOdmZxRXBid0hILXNoTFRqR1BfVUxYd0d5LVdEdUxadnpqdXdPVEEwZ3NISHVIaTFmWU05XzJqY0xDLUt6czU1SWxvak8xeDBpSHVWWC1FdmZmcTBFUkRBb25jaHgyRnJ3UmNqaHFxSnBkT0d1QzBFRFpLY1FXRUlJTDVES2VNWFl1WFgyUjBHTVFJeTFBRGxfVUtCaUtJbjZ6ZkNvUVM3UnNlNmNrdmlsUi1XUENsUQ?oc=5" target="_blank">The Survival Signal That Should Redesign Every RAS-Mutant Pancreatic Trial Running Right Now</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Read Full StoryMore like this
This new drug could change how we treat one of the deadliest cancers
PBSgeneral

This new drug could change how we treat one of the deadliest cancers

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOM2hzWDZ2ZHN2YkkxaTRZenVHRkZtWjlHczBRZTF3TE1NRmIzNi1SN1dURlhqX09ENzlVS2xEcHFndE80YlZITGZ3cWY4bjVKNDV4VDU2akFGYy14bkNMVEVORjl2OURYUnRfeGtFTG5FazhnUTV0b0dTeDFjeU00VkYxT2YtMmVHRW1uNkRwQXdBTFRHWWdfWVg2SjBWdFFNdGhWTzg2N2NSb1J1ejlLOVFxZm9NQQ?oc=5" target="_blank">This new drug could change how we treat one of the deadliest cancers</a>  <font color="#6f6f6f">PBS</font>

Read Full StoryMore like this
FDA Allows Expanded Access to Daraxonrasib for PDAC
Targeted Oncologygeneral

FDA Allows Expanded Access to Daraxonrasib for PDAC

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQRU1yN3gxV1hYcUpuLVgtSEdqYlVldVZ5VmpjUUhGVGxTOFhqcHZ2bmVDU2dxQ0lvUWNVU2xvWXU2cjFlSnpTaWxNSV9hSXo0WlF5ZDNOX0g4Yk40b0FCMC1SeWY5bURDXzdaNmtKbWlqY1c2VjlhRXJ4eGc2cDJ1TWZHQUVjakpTRFdFMg?oc=5" target="_blank">FDA Allows Expanded Access to Daraxonrasib for PDAC</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Naturegeneral

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5YTkpGNlJUM09WSUU5eGFMWjR4UTQ4b1JmU3R5eDc1MjhZa1lndkphU3ZNc1JHWFQwak5jU3NxWVIxU01uZDJnRmxHbk5Qdm9TMGN5LXdmY2VjQUFMdkQ0?oc=5" target="_blank">Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment
Frontiersgeneral

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxORFgzSDkwMFlSR0gzX21yZmUtZUdJa3BNTTdqNXY2ZS1NanBnY0kybWJYRmVjYkRDb2FacVpneElLaFpyWGJqVkZpU0djZHpJNW5RTTVpcWpPejNSSkRxV2RxLUdLQUZVSVZuY3JHQ25HQm1TMHktZFNENnpZbzh5LXEzN3RIZTIwY3V5MTJB?oc=5" target="_blank">Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Propanc’s pancreatic cancer candidate extends animal survival more than 2.5-fold
Stock Titangeneral

Propanc’s pancreatic cancer candidate extends animal survival more than 2.5-fold

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOR3FLdGN2dEt2ZTRYUVVEQTZpNDIxTzJ5YU82bWtmRFd3akZDRzNucHl5NExqS0MtOW0yd21QTnhWcnhrcTJEc3AwbEFtamJBR0VyZG4tbkVWU0ZpN3R4TmU4SjY2QXJ3aW9ENWZFRncxRUlXRURkWDM0SGtseEVKZ0VGdG55Zl9Ha0RFOU42N0tFcm14bVdBdTY3T3A0Z292RjRxZ3JBNldOeVNIS1NvemhnNUE3UXZHOGRXSg?oc=5" target="_blank">Propanc’s pancreatic cancer candidate extends animal survival more than 2.5-fold</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
Naturegeneral

Pan-KRAS inhibitor disables oncogenic signalling and tumour growth

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBlbVVBeHZJY3VBaXljRV9MMmw2WUtVS1VSajZxbzVWUWxlTVFHWGx4alZhaXk5aVBUU3RPcnRPMkVraGQ4YWtmLS1MaTRkYmo0ZFkyWHBMZi0xTjlVYUNN?oc=5" target="_blank">Pan-KRAS inhibitor disables oncogenic signalling and tumour growth</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
Naturegeneral

A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9weWNuMmZrUWRXN3NJanN5eTdvU2N2aFdDUm5ZZXV3SVFxVFlhczRWTnRZcGlzTmpwU2Vqc1BxeXZubmFzUmNZZGFKT3pha3JoTW05bEpaa2d3ell0ZmpZ?oc=5" target="_blank">A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Treeline reaps $200M series A extension, plucks first 3 clinical candidates
Fierce Biotechgeneral

Treeline reaps $200M series A extension, plucks first 3 clinical candidates

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQkZRdEIybkRBQ0JHcWlhb010bjVGV3JndF9aWkJvUWNWdWZ1OHBJc0gxdFR5MHJTdjFfdERLT0hUUGIxMTFlLUhvNzJVVVJhMGVUaVJhNU5WNWNvREtBaFlqd0E2NlRjMk9FbEpNLV83Y0hUenNscTFUMmpTWm13bUdvNTgxQmpVcjRTZkpwUndrZnExNXBWUkpHd05fZDZFQ0dJNXhvd3R3SFdpOGJNNV9ON3g2ZVcwOHNV?oc=5" target="_blank">Treeline reaps $200M series A extension, plucks first 3 clinical candidates</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Hanmi Pharmaceutical Unveils Preclinical Data on FAP-Targeting SMDC, Confirming Extended Survival in Pancreatic Cancer
BigGo Financeworld

Hanmi Pharmaceutical Unveils Preclinical Data on FAP-Targeting SMDC, Confirming Extended Survival in Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE4zckJyQTNYR3NrSUgzQTc4QjhkTFRYbnozVGowNGJtX2M3YlltX3hEa18wVGh5Z0xCRjczWHpfaUdLZzhIREtoNTd1RjN0dlMwVlNKQTdodHEzaU9OYUZaWEVFaTFfQnRWWFcwMWNEdXhvOXlpWmc?oc=5" target="_blank">Hanmi Pharmaceutical Unveils Preclinical Data on FAP-Targeting SMDC, Confirming Extended Survival in Pancreatic Cancer</a>  <font color="#6f6f6f">BigGo Finance</font>

Read Full StoryMore like this
"First RAS Inhibitor Exten" — Live Google News Trends & Headlines